The Therapeutic Effects of Sodium Cromoglycate Against Influenza A Virus H5N1 in Mice

Deping Han,Tangting Wei,Siyi Zhang,Ming Wang,Haiyan Tian,Jinlong Cheng,Jin Xiao,Yanxin Hu,Mingyong Chen
DOI: https://doi.org/10.1111/irv.12334
2015-01-01
Influenza and Other Respiratory Viruses
Abstract:OBJECTIVES:To identify the protective role of sodium cromoglycate in mice during influenza virus infection.DESIGN:H5N1 virus-infected mice were treated with the mast cell stabilizer sodium cromoglycate (SCG) to investigate its therapeutic effect.SAMPLE:The nose, trachea and lungs from mice were collected.MAIN OUTCOME MEASURES:Virus replication and host responses were determined by plaque assay, quantitative PCR, immunohistochemistry, and histology.RESULTS:SCG-treated mice survived better than did PBS-treated mice after H5N1 virus infection. Mild pathological changes with fewer inflammatory cell infiltration and fewer virus antigens were observed in the nose, trachea, and lungs of SCG-treated mice on days 3 and 5 post-infection. However, no significant changes in viral load in the lungs were detected between SCG- and PBS-treated mice. Furthermore, significantly decreased expression of interleukin-6, tumor necrosis factor-a, Toll-like receptor 3, and TIR-domain-containing adapter-inducing interferon-b was detected in the lungs of SCG-treated mice, and no higher expression of interferon-c was detected.CONCLUSION:These results suggest that SCG has therapeutic roles in H5N1 virus-infected mice by alleviating the inflammatory response rather than inhibition of viral replication in the lungs.
What problem does this paper attempt to address?